OTC : AGNPF

Grey Matters Health Inc. — News

$0.3098 USD

$0.04 (12.74%)

Volume
2K
Average Volume
9.82K
Market Capitalization
$1.68M
P/E Ratio
Dividend Yield
%
Price Target
Year High
$0.64
Year Low
$0.22
Day High
Day Low
Payout Ratio
Current Ratio
Source Headline
Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.

VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it plans to open its flagship NovaScan Neuroimaging ClinicsTM location next month in Davie, Florida and conduct a brain PET scan of its first patient by September 30th, 2026.

globenewswire.com - 2026-08-04 07:00:00

Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.

globenewswire.com - 2026-07-06 07:00:00

Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce an increase to its non-brokered private placement (the “Offering”), previously announced on April 22, 2026 and updated on May 25, 2026 and June 5, 2026 to $1,250,000 and the closing of the second and final tranche (the “Second Tranche”). Gross proceeds from the Second Tranche totalled CAD $750,000 from the sale of 1,875,000 units (the “Units”) at an issue price of CAD $0.40 per Unit.

globenewswire.com - 2026-06-18 07:00:00

Grey Matters Closes First Tranche of $500,000 of its Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 05, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce the closing of the first tranche (the “First Tranche”) of its non-brokered private placement (the “ Offering”), previously announced on April 22, 2026 and updated on May 25, 2026. Gross proceeds from the First Tranche totalled CAD $500,000 from the sale of 1,250,000 units (the “Units”) at an issue price of CAD $0.40 per Unit.

globenewswire.com - 2026-06-05 16:01:00

Grey Matters Improves Warrant Terms of Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 25, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has amended the warrant terms of its recently announced non-brokered private placement, removing the acceleration feature and extending the warrant exercise period to 3 years. All other terms remain unchanged.

globenewswire.com - 2026-05-25 07:00:00

Grey Matters Improves Warrant Terms of Private Placement

NOT FOR DISTRIBUTION TO U. S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 25, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the "Company" or "Grey Matters") (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has amended the warrant terms of its recently announced non-brokered private placement, removing the acceleration feature and extending the warrant exercise period to 3 years.

globenewswire.com - 2026-05-25 07:00:00

Grey Matters Health Signs LOI with Catalyst MedTech for 200 Brain PET Scans for Alzheimer's Clinical Trial at 2nd NovaScan Location Planned for Tampa

VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer's Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company's NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida.

globenewswire.com - 2026-05-20 07:00:00

Get AGNPF Insider Trade Alerts

AGNPF Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

AGNPF Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade